![Jordan Johnson: Major Developments in Government Oversight](https://oncodaily.com/pub/uploads/2024/09/J.png)
Jordan Johnson: Major Developments in Government Oversight
Jordan Johnson, Founding Partner at Bridge Oncology, shared a post on LinkedIn:
“Major Developments in Government Oversight.
Elon Musk’s Department of Government Efficiency (DOGE) is making waves inside U.S. agencies – including the Centers for Medicare and Medicaid Services (CMS) – by conducting deep dives into federal spending, targeting what they consider fraud and waste. DOGE has accessed CMS payment and contracting systems and is working to cancel diversity, equity, and inclusion (DEI) contracts, including those with Deloitte.
CMS, which oversees $1.5 trillion in Medicare and Medicaid spending (22% of the federal budget), has two veteran employees assisting DOGE in its review. Musk’s team is also shaking up the Treasury Department and USAID, reportedly leading to administrative leave for thousands of employees. However, their actions have triggered internal resistance, lawsuits from unions, and concerns over government transparency and oversight.
With Musk confirmed as a special government employee (SGE) and President Trump’s recent firing of multiple inspectors general, including one responsible for policing Medicare fraud, this initiative raises questions about the future of government spending, accountability, and the role of private influence in federal oversight.
What are your thoughts? Is this an overdue effort to eliminate waste or a dangerous shake-up with unintended consequences?“
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023